A nanovaccine for immune activation and prophylactic protection of atherosclerosis in mouse models

Vaccines offer prophylactic treatments against atherosclerosis by eliciting effector T cell and antibody responses, which require effective delivery of antigen and adjuvant to activate dendritic cells (DC). Here we show that individual conjugation of antigen p210 and adjuvant CpG oligodeoxynucleotides onto superparamagnetic iron oxide nanoparticles formulates a nanovaccine cocktail that activates DCs for antigen cross-presentation and induction of co-stimulatory signals, cytokines and CD8<sup>+</sup> effector/effector memory T cell responses. This nanovaccine modulates the DCs in the draining lymph nodes, activates both CD4<sup>+</sup> and CD8<sup>+</sup> T cells, elicits memory responses, and induces both anti-p210 IgM and IgG antibodies to suppress atherosclerosis. Lastly, three intradermal vaccinations of this nanovaccine mitigate the atherosclerosis development in the ApoE<sup>-/-</sup> mice. Our nanovaccine design and preclinical data thus presents a potential candidate for prophylactic treatment for atherosclerosis.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2025-03-02
DOI
https://doi.org/10.1038/s41467-025-57467-5
Citations
9
Primary Topic
Atherosclerosis and Cardiovascular Diseases
Type
article
Field-Weighted Citation Impact
7.18

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A nanovaccine for immune activation and prophylactic protection of atherosclerosis in mouse models

Xiaoling Ma, Lei Zhang, Weixiao Ding, Xinmeng Li et al.
9 citations
Nature Communications
Atherosclerosis and Cardiovascular Diseases
7.18
article

A nanovaccine for immune activation and prophylactic protection of atherosclerosis in mouse models

Xiaoling Ma, Lei Zhang, Weixiao Ding, Xinmeng Li, Wanying Zhu, Dan-Xuan Zhu, Dongping Sun, Chuntao Chen, Chao Zuo, Abdulrahman AL-Ammari, Hongsong Zhang, Peng Zhou, Jiaan Zhang, Xu Zhi, Qingqing Yu, Y. Gai
article en
9 citations

Abstract

Vaccines offer prophylactic treatments against atherosclerosis by eliciting effector T cell and antibody responses, which require effective delivery of antigen and adjuvant to activate dendritic cells (DC). Here we show that individual conjugation of antigen p210 and adjuvant CpG oligodeoxynucleotides onto superparamagnetic iron oxide nanoparticles formulates a nanovaccine cocktail that activates DCs for antigen cross-presentation and induction of co-stimulatory signals, cytokines and CD8<sup>+</sup> effector/effector memory T cell responses. This nanovaccine modulates the DCs in the draining lymph nodes, activates both CD4<sup>+</sup> and CD8<sup>+</sup> T cells, elicits memory responses, and induces both anti-p210 IgM and IgG antibodies to suppress atherosclerosis. Lastly, three intradermal vaccinations of this nanovaccine mitigate the atherosclerosis development in the ApoE<sup>-/-</sup> mice. Our nanovaccine design and preclinical data thus presents a potential candidate for prophylactic treatment for atherosclerosis.

Nature CommunicationsVol. 16(1)
University of Science and Technology of China (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Nanjing University of Science and Technology (CN), Jiangsu Province Hospital (CN), Nanjing Medical University (CN), Nanjing University (CN)
National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province
Openalex Percentile: Top 3%
Atherosclerosis and Cardiovascular Diseases
7.18
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.